# PharmaCyte Biotech, Inc.: Form 8-K, filed Apr 2, 2026

- Company: [PharmaCyte Biotech, Inc.](/companies/pmcb.md) (CIK 1157075)
- Form: 8-K
- Filed: 2026-04-02
- Accepted by EDGAR: Apr 2, 2026, 20:19 ET
- Period: 2026-03-30
- Accession: 0001683168-26-002613
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1157075/000168316826002613/pharmacyte_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1157075/000168316826002613/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1157075/000168316826002613/pharmacyte_8k.htm

Filed Apr 2, 2026.
Source: SEC EDGAR, the filing index for accession 0001683168-26-002613. Last ingested by Listed: Oct 24, 2026, 15:05 ET. No prices; not investment advice.